Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.530
+0.030 (2.00%)
Jan 21, 2025, 4:00 PM EST - Market closed
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $90.98 million as of January 21, 2025. Its market cap has increased by 1.16% in one year.
Market Cap
90.98M
Enterprise Value
-33.30M
1-Year Change
1.16%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $90.98M, a decrease of -82.63%. That is a compound annual growth rate of -41.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 89.20M | -3.85% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |